PCM
HPTX

Prelude Capital Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Prelude Capital Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,552
Closed -$163K – 2359
2015
Q1 		$163K Buy
3,552
+2,152
+154% +$64.4K 0.02% 736
2014
Q4 		$34K Sell
1,400
-5,700
-80% -$128K 0.01% 1579
2014
Q3 		$179K Buy
7,100
+1,200
+20% +$29.8K 0.03% 761
2014
Q2 		$154K Buy
+5,900
New +$152K 0.02% 856

Prelude Capital Management's HPTX Position: Q2 2015 in Review

Prelude Capital Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 3,552 shares — an estimated $163K sold.

Prelude Capital Management first reported a position in HPTX in Q2 2014 and held it in 4 quarters. The position peaked at $179K in Q3 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Prelude Capital Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Prelude Capital Management sold 3,552 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $163K.
  • Prelude Capital Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • Prelude Capital Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $179K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Prelude Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.